FDA Inspection
Genzyme CorporationGenzyme Corporation – FDA Inspection, Aug 18, 2016
Record Details
This FDA Inspection record concerns Genzyme Corporation, with an inspection on August 18, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Genzyme Corporation
- Inspection Date
- August 18, 2016
- Product Type
- Drugs
View Company Profile
ID · d555abbb-6d54-45b1-952c-255134546f9d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 985381
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(a)Deviations from laboratory control requirements
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Genzyme Corporation
7| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2025 | VAI | New England District Office | Blood and Blood Products |
| February 28, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 19, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 18, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Genzyme Corporation
- FDA Inspection 1281578 - 2025-08-14
- FDA Inspection 1261312 - 2025-02-14
- FDA Inspection 1120993 - 2020-02-28
- FDA Inspection 1062695 - 2018-07-19
- FDA Inspection 896910 - 2014-09-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.